MedPath

Kineesiotaping for Patients With LCPD

Not Applicable
Completed
Conditions
Legg-Calve-Perthes Disease
Interventions
Other: Kinesiotaping
Other: Sham taping
Registration Number
NCT05840146
Lead Sponsor
Istanbul University - Cerrahpasa (IUC)
Brief Summary

Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).

Detailed Description

Kinesio taping is increasingly being used as a complement to musculoskeletal pain management. A randomized, double-blind, placebo-controlled clinical trial was conducted. Activity-related hip pain, passive and pain limited hip range of motion, gluteus medius muscle strength, function and balance were assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Having received unilateral LCPD diagnosis,
  • Anterior hip pain minimum three points on 10-cm Visual Analog Scale (VAS) over the previous week,
  • Having the following symptoms; weakness of gluteus medius muscle and patient-reported complaints on function or balance
Exclusion Criteria
  • Having a history of any other hip pathologies,
  • Having allergy to polyacrylate adhesive,
  • Having used analgesic medication within the previous three days.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Kinesiotaping groupKinesiotapingKinesiotape was applied to the lateral side of the affected hip for gluteus medius muscle. Each patient was positioned lying down with the affected side up, and two I-strips were used.
Sham taping groupSham tapingSham tape was applied with a single I-strip without tension in tape or muscle stretch. After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the affected hip.
Primary Outcome Measures
NameTimeMethod
Immediate Clinical Efficacy on Activity Related HipThe change between T1 (baseline) to T2 (thirty minutes later from the application)

Horizontal 10 cm VAS (0, no pain; 10, the worst pain ever possible)

Secondary Outcome Measures
NameTimeMethod
Immediate Clinical Efficacy on Functional Task DurationsThe change between T1 (baseline) to T2 (thirty minutes later from the application)

10-meters walk task duration (sec) and 10-step climbing task duration (sec)

Immediate Clinical Efficacy on Gluteus medius muscle strengthThe change between T1 (baseline) to T2 (thirty minutes later from the application)

muscle strength by handheld dynamometer (Ibs)

Immediate Clinical Efficacy on Balance test durationsThe change between T1 (baseline) to T2 (thirty minutes later from the application)

One leg stance test duration (sec) and Tandem walk test duration (sec)

Immediate Clinical Efficacy on Hip Abduction ROMThe change between T1 (baseline) to T2 (thirty minutes later from the application)

goniometric range of motion (ROM)

Trial Locations

Locations (1)

Istanbul University-Cerrahpasa

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath